Washington, DC 20006-5349
HELPLINE
Today, the Meso Foundation wrote a letter to the acting administrator of the EPA urging the agency to account for legacy asbestos when evaluating asbestos risk and the magnitude of the asbestos problem. This letter came as a response to the EPA’s decision to exclude legacy uses of asbestos in its problem formulation. This issue is separate from the recently publicized ‘significant new use rule.’ You can read more here.
EPA_Legacy_Comment_MesoFoundation
The Mesothelioma Applied Research Foundation is seeking participants for a study focused on understanding the experiences and challenges of caregivers of mesothelioma patients. The study, which is
Mesothelioma is one of the rarest cancers so there are always clinical trials going on to advance research efforts. This session presents on four different
Peritoneal mesothelioma patients have a few different treatment options available. This session discusses two options: surgery as well as hyperthermic intraperitoneal chemotherapy (HIPEC). This session
Get the latest information about mesothelioma, clinical trials, patient stories, community events, and much more!
